Clinical Trials Directory

Trials / Completed

CompletedNCT03142789

Adductor Canal Block After Total Knee Replacement - a Suture-method Catheter vs a Standard Catheter vs a Single Bolus

Comparison of the Analgesic Effect of an ACB (Adductor Canal Block) Using a New Suture-method Catheter vs a Standard Perineural Catheter vs a Single Bolus: A Randomized, Blinded, Controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
153 (actual)
Sponsor
University Hospital, Gentofte, Copenhagen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study we wish to investigate the analgesic effect of the administration of 0.2% ropivacaine for an adductor canal block as repeated boluses (20 ml every 8 hours) through a new suture-method catheter or a standard perineural catheter compared with a single bolus (20 ml), in patients following primary total knee arthroplasty.

Detailed description

The aim of the study is to compare the clinical effects of three different administration forms for an ACB: repeated intermittent boluses through a Certa catheter (CC) versus repeated boluses through a standard catheter (through the needle) (SC) versus a single bolus (SB). Our dual hypothesis is that repeated boluses through a catheter (either Certa or standard catheter) reduces opioid consumption (primary outcome), as well as reduces pain scores, enhances ambulation and muscle strength compared with a single bolus, and that the Certa catheter is superior to a standard catheter.

Conditions

Interventions

TypeNameDescription
DRUGInitial bolus (Certa and standard catheter groups)10 ml of ropivacaine 0,75% will be used to ensure correct position of the needle and to expand the adductor canal, followed by injection of another 10 ml of ropivacaine 0.75% via the catheter during real time US imaging to ensure correct placement of the catheter.
DRUGInitial bolus (Single bolus group)20 ml of ropivacaine 0.75%
DRUGIntermittent boluses (Certa and standard catheter groups)20 ml of ropivacaine 0.2% every 8 hour in the catheter
DRUGIntermittent boluses (Single bolus group)0.1ml of ropivacaine 0.2% every 8 hour in the sham catheter

Timeline

Start date
2017-05-09
Primary completion
2018-04-12
Completion
2018-04-12
First posted
2017-05-05
Last updated
2018-05-01

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03142789. Inclusion in this directory is not an endorsement.